| Asset | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 | 31 Jan 2026 | 31 Dec 2025 |
|---|---|---|---|---|---|---|
| Equity | 100.09% | 100.08% | 99.86% | 101.41% | 100.01% | 100.06% |
| Debt | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Others (incl. cash) | -0.09% | -0.08% | 0.15% | -1.41% | -0.01% | -0.06% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| Lupin Ltd. | Healthcare | 69,901 | 15.85 | 9.15% | -0.73%↓ |
| Laurus Labs Ltd. | Healthcare | 1,12,136 | 15.27 | 8.82% | 1.25%↑ |
| Fortis Healthcare Ltd. | Healthcare | 1,50,191 | 13.94 | 8.05% | -0.45%↓ |
| Aurobindo Pharma Ltd. | Healthcare | 80,564 | 11.49 | 6.64% | -0.22%↓ |
| Glenmark Pharmaceuticals Ltd. | Healthcare | 43,394 | 9.87 | 5.70% | -0.70%↓ |
| Alkem Laboratories Ltd. | Healthcare | 16,864 | 9.27 | 5.35% | -0.23%↓ |
| Biocon Ltd. | Healthcare | 2,05,693 | 8.82 | 5.09% | 0.55%↑ |
| Mankind Pharma Ltd. | Healthcare | 32,609 | 7.75 | 4.47% | -0.02%↓ |
| Ipca Laboratories Ltd. | Healthcare | 40,027 | 6.1 | 3.52% | -0.24%↓ |
| Krishna Institute of Medical Sciences Ltd | Healthcare | 71,181 | 5.4 | 3.12% | 0.21%↑ |
| Aster DM Healthcare Ltd. | Healthcare | 72,970 | 5.31 | 3.07% | -0.07%↓ |
| Gland Pharma Ltd. | Healthcare | 22,937 | 5.16 | 2.98% | 0.52%↑ |
| JB Chemicals & Pharmaceuticals Ltd. | Healthcare | 23,592 | 5.11 | 2.95% | -0.01%↓ |
| Wockhardt Ltd. | Healthcare | 23,808 | 4.84 | 2.79% | 0.75%↑ |
| Sai Life Sciences Ltd. | Healthcare | 39,657 | 4.6 | 2.66% | 0.06%↑ |
| Neuland Laboratories Ltd. | Healthcare | 2,485 | 4.25 | 2.45% | 0.16%↑ |
| Abbott India Ltd. | Healthcare | 1,500 | 4.03 | 2.33% | -0.01%↓ |
| Narayana Hrudayalaya Ltd. | Healthcare | 19,913 | 3.77 | 2.18% | 0.02%↑ |
| Dr. Lal Pathlabs Ltd. | Healthcare | 22,448 | 3.61 | 2.08% | 0.20%↑ |
| Ajanta Pharma Ltd. | Healthcare | 12,140 | 3.56 | 2.05% | -0.05%↓ |
| Sector | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 | 31 Jan 2026 | 31 Dec 2025 |
|---|---|---|---|---|---|---|
| Healthcare | 100.09% | 100.08% | 99.86% | 101.41% | 100.01% | 100.06% |
27.4 / 100
Weighted average Value score is 27.4. This indicates that portfolio is relatively reasonably valued using composite of value measures.
79.6 / 100
Weighted average Price Momentum score is 79.6. This indicates that portfolio has high momentum using composite of momentum measures.
82.6 / 100
Weighted average Quality score is 82.6. This indicates that portfolio has high quality using composite of quality measures.
72.4 / 100
Weighted average QVM score is 72.4. This indicates that portfolio has average QVM score and hence a neutral stance is warranted.
